FindTrial
Sign In

TaurusOne Transcatheter Aortic Valve System – A Retrospective Cohort Study

TaurusOne Transcatheter Aortic Valve System – A Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109740
Enrollment
Unknown
Registered
2025-09-24
Start date
2025-09-30
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stenosis

Interventions

TAVR group:None

Sponsors

Fujian Medical University Union Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with severe aortic stenosis who underwent transcatheter aortic valve replacement with the TaurusOne® System in the Department of Cardiac Surgery at Fujian Medical University Union Hospital were retrospectively enrolled between April 2022 and January 2025.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Secondary

MeasureTime frame
Technical success rate;Device success rate;NYHA functional class;Performance of the valve;—

Primary

MeasureTime frame
All-cause mortality;—

Countries

China

Contacts

Public ContactXiaofu Dai

Fujian Medical University Union Hospital

1449675412@qq.com+86 133 6591 2195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026